bupivacaine has been researched along with cromakalim in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Attolini, L; Bruguerolle, B; Gantenbein, M | 2 |
Bassoul, B; Bruelle, P; de La Coussaye, JE; Desch, G; Eledjam, JJ; Gagnol, JP; Lefrant, JY; Peray, P; Sassine, A | 1 |
Dojo, M; Hatano, Y; Kimoto, Y; Kinoshita, H; Nakahata, K | 1 |
An, S; Bae, SI; Hong, JM; Kang, D; Kim, EJ; Kim, HJ; Kim, JY; Kwon, SC; Lee, SH; Ok, SH; Sohn, JT | 1 |
5 other study(ies) available for bupivacaine and cromakalim
Article | Year |
---|---|
Effect of four potassium channel agonists on bupivacaine-induced toxicity in mice.
Topics: Animals; Benzopyrans; Bupivacaine; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Guanidines; Male; Mice; Mice, Inbred Strains; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Pyrroles; Seizures | 1995 |
Lemakalim, a potassium channel agonist, reverses electrophysiological impairments induced by a large dose of bupivacaine in anaesthetized dogs.
Topics: Anesthesia, General; Animals; Atropine; Benzopyrans; Bupivacaine; Cromakalim; Dogs; Electrocardiography; Female; Heart; Heart Rate; Male; Potassium Channels; Pyrroles; Time Factors | 1993 |
Kinetics of bupivacaine after levcromakalim treatment in mice.
Topics: Anesthetics, Local; Animals; Benzopyrans; Bupivacaine; Cromakalim; Drug Synergism; Male; Mice; Pyrroles; Vasodilator Agents | 1997 |
Effects of bupivacaine enantiomers and ropivacaine on vasorelaxation mediated by adenosine triphosphate-sensitive K(+) channels in the rat aorta.
Topics: Amides; Anesthetics, Local; Animals; Aorta, Thoracic; Bupivacaine; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Male; Membrane Proteins; Muscle, Smooth, Vascular; Papaverine; Potassium Channels; Rats; Rats, Wistar; Ropivacaine; Stereoisomerism; Vasodilation; Vasodilator Agents | 2004 |
Linoleic Acid Attenuates the Toxic Dose of Bupivacaine-Mediated Reduction of Vasodilation Evoked by the Activation of Adenosine Triphosphate-Sensitive Potassium Channels.
Topics: Animals; Bupivacaine; Cromakalim; Emulsions; Genistein; HEK293 Cells; Humans; Indoles; Ion Channel Gating; KATP Channels; Linoleic Acid; Lipids; Male; Maleimides; Membrane Potentials; Phosphorylation; Protein Kinase C; Rats, Sprague-Dawley; Vasodilation | 2018 |